- Home
- BDC vs RNA Comparison
BDC vs RNA Comparison
Compare BDC & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDC
- RNA
- Stock Information
- Founded
- BDC 1902
- RNA 2012
- Country
- BDC United States
- RNA United States
- Employees
- BDC N/A
- RNA N/A
- Industry
- BDC Telecommunications Equipment
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- BDC Telecommunications
- RNA Health Care
- Exchange
- BDC Nasdaq
- RNA Nasdaq
- Market Cap
- BDC 4.1B
- RNA 3.4B
- IPO Year
- BDC 1993
- RNA 2020
- Fundamental
- Price
- BDC $112.38
- RNA $28.35
- Analyst Decision
- BDC Strong Buy
- RNA Strong Buy
- Analyst Count
- BDC 6
- RNA 12
- Target Price
- BDC $126.83
- RNA $67.92
- AVG Volume (30 Days)
- BDC 248.4K
- RNA 1.4M
- Earning Date
- BDC 05-01-2025
- RNA 05-08-2025
- Dividend Yield
- BDC 0.18%
- RNA N/A
- EPS Growth
- BDC 1.04
- RNA N/A
- EPS
- BDC 5.17
- RNA N/A
- Revenue
- BDC $2,550,165,000.00
- RNA $8,927,000.00
- Revenue This Year
- BDC $8.57
- RNA N/A
- Revenue Next Year
- BDC $5.05
- RNA $121.50
- P/E Ratio
- BDC $21.83
- RNA N/A
- Revenue Growth
- BDC 5.99
- RNA N/A
- 52 Week Low
- BDC $83.18
- RNA $21.51
- 52 Week High
- BDC $131.82
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- BDC 67.13
- RNA 46.14
- Support Level
- BDC $112.23
- RNA $25.58
- Resistance Level
- BDC $114.70
- RNA $30.84
- Average True Range (ATR)
- BDC 2.62
- RNA 2.33
- MACD
- BDC 1.32
- RNA -0.20
- Stochastic Oscillator
- BDC 88.39
- RNA 31.14
About BDC Belden Inc
Belden Inc provides signal transmission products to distributors, end-users, installers, and original equipment manufacturers. The firm operates in two segments - Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions segment is a provider in network infrastructure and broadband solutions, as well as cabling and connectivity solutions for commercial audio/video and security applications. Automation Solutions segment provides network infrastructure and digitization solutions to enable customers to make data-based business decisions. It operates in Americas, EMEA and APAC, out of which maximum revenue from Americas.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.